These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25009488)

  • 21. Three-decade neurological and neurocognitive follow-up of HIV-1-infected patients on best-available antiretroviral therapy in Finland.
    Heikinheimo T; Poutiainen E; Salonen O; Elovaara I; Ristola M
    BMJ Open; 2015 Nov; 5(11):e007986. PubMed ID: 26546135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurocognitive and quality of life study in perinatally HIV-infected young people and their peers. NeuroCoRISpeS study.
    García-Navarro C; Martín-Bejarano M; Jimenez de Ory S; Zamora B; Ruiz-Saez B; Velo C; Cuéllar-Flores I; Garcia Lopez-Hortelano M; Guillen-Martin S; Navarro-Gómez ML; Ramos JT; González-Tomé MI;
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Nov; 38(9):417-424. PubMed ID: 32113706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal neurological follow-up of a group of HIV-seropositive and HIV-seronegative hemophiliacs: results from the hemophilia growth and development study.
    Mitchell WG; Lynn H; Bale JF; Maeder MA; Donfield SM; Garg B; Tilton AH; Willis JK; Bohan TP
    Pediatrics; 1997 Nov; 100(5):817-24. PubMed ID: 9346981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurocognitive functioning in acute or early HIV infection.
    Moore DJ; Letendre SL; Morris S; Umlauf A; Deutsch R; Smith DM; Little S; Rooney A; Franklin DR; Gouaux B; Leblanc S; Rosario D; Fennema-Notestine C; Heaton RK; Ellis RJ; Atkinson JH; Grant I;
    J Neurovirol; 2011 Feb; 17(1):50-7. PubMed ID: 21165782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.
    de Almeida SM; de Pereira AP; Pedroso MLA; Ribeiro CE; Rotta I; Tang B; Umlauf A; Franklin D; Saloner RG; Batista MGR; Letendre S; Heaton RK; Ellis RJ; Cherner M;
    J Neurovirol; 2018 Jun; 24(3):339-349. PubMed ID: 29516346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive impairment and gray matter volume reduction in HIV-infected patients.
    Kato T; Yoshihara Y; Watanabe D; Fukumoto M; Wada K; Nakakura T; Kuriyama K; Shirasaka T; Murai T
    J Neurovirol; 2020 Aug; 26(4):590-601. PubMed ID: 32572834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for postnatal mother-child transmission of HIV-1.
    Embree JE; Njenga S; Datta P; Nagelkerke NJ; Ndinya-Achola JO; Mohammed Z; Ramdahin S; Bwayo JJ; Plummer FA
    AIDS; 2000 Nov; 14(16):2535-41. PubMed ID: 11101065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered structural brain changes and neurocognitive performance in pediatric HIV.
    Yadav SK; Gupta RK; Garg RK; Venkatesh V; Gupta PK; Singh AK; Hashem S; Al-Sulaiti A; Kaura D; Wang E; Marincola FM; Haris M
    Neuroimage Clin; 2017; 14():316-322. PubMed ID: 28224079
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurocognitive impairments in hiv infection.
    Edwin T; Nammalvar N; Sabhesan S; Ganesh R; Devarajan H
    Indian J Psychiatry; 1999 Jan; 41(1):30-6. PubMed ID: 21455350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurodevelopment in perinatally HIV-infected children: a concern for adolescence.
    Laughton B; Cornell M; Boivin M; Van Rie A
    J Int AIDS Soc; 2013 Jun; 16(1):18603. PubMed ID: 23782482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Empiric neurocognitive performance profile discovery and interpretation in HIV infection.
    Gomez D; Power C; Gill MJ; Koenig N; Vega R; Fujiwara E
    J Neurovirol; 2019 Feb; 25(1):72-84. PubMed ID: 30519968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive Impairment in the Combined Antiretroviral Therapy Era in a Romanian Cohort of Young Adults with Chronic HIV Infection.
    Temereanca A; Ene L; Rosca A; Diaconu CC; Luca A; Burlacu R; Radoi R; Bulacu-Talnariu A; Marcotte TD; Achim CL; Ruta S
    AIDS Res Hum Retroviruses; 2020 May; 36(5):367-372. PubMed ID: 31476875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translational spatial task and its relationship to HIV-associated neurocognitive disorders and apolipoprotein E in HIV-seropositive women.
    Morales D; Acevedo SF; Skolasky RL; Hechavarria R; Santiago S; De La Torre T; Maldonado E; Wojna V
    J Neurovirol; 2012 Dec; 18(6):488-502. PubMed ID: 22972599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.
    Wächter C; Eiden LE; Naumann N; Depboylu C; Weihe E
    J Neuroinflammation; 2016 Oct; 13(1):272. PubMed ID: 27737697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of ageing on neurocognitive function by stage of HIV infection: evidence from the Multicenter AIDS Cohort Study.
    Goodkin K; Miller EN; Cox C; Reynolds S; Becker JT; Martin E; Selnes OA; Ostrow DG; Sacktor NC;
    Lancet HIV; 2017 Sep; 4(9):e411-e422. PubMed ID: 28716545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of AIDS diagnoses on long-term neurocognitive and psychiatric outcomes of surviving adolescents with perinatally acquired HIV.
    Wood SM; Shah SS; Steenhoff AP; Rutstein RM
    AIDS; 2009 Sep; 23(14):1859-65. PubMed ID: 19584705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive dysfunction in HIV-infected youth: investigating the relationship with immune activation.
    Eckard AR; Rosebush JC; O'Riordan MA; Graves CC; Alexander A; Grover AK; Lee ST; Habib JG; Ruff JH; Chahroudi A; McComsey GA
    Antivir Ther; 2017; 22(8):669-680. PubMed ID: 28327462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-1 infection incidence among persons with hemophilia in the United States and western Europe, 1978-1990. Multicenter Hemophilia Cohort Study.
    Kroner BL; Rosenberg PS; Aledort LM; Alvord WG; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1994 Mar; 7(3):279-86. PubMed ID: 8106967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurocognitive effects of HIV, hepatitis C, and substance use history.
    Devlin KN; Gongvatana A; Clark US; Chasman JD; Westbrook ML; Tashima KT; Navia B; Cohen RA
    J Int Neuropsychol Soc; 2012 Jan; 18(1):68-78. PubMed ID: 22132928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
    Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
    J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.